128 related articles for article (PubMed ID: 36427370)
1. miRNA-21, which disrupts metabolic reprogramming to facilitate CD4
Sun J; Wu M; Wang L; Wang P; Xiao T; Wang S; Liu Q
Ecotoxicol Environ Saf; 2022 Dec; 248():114321. PubMed ID: 36427370
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA HOTAIR via miR-17-5p is involved in arsenite-induced hepatic fibrosis through regulation of Th17 cell differentiation.
Wu M; Sun J; Wang L; Wang P; Xiao T; Wang S; Liu Q
J Hazard Mater; 2023 Feb; 443(Pt B):130276. PubMed ID: 36332283
[TBL] [Abstract][Full Text] [Related]
3. miR-21-regulated M2 polarization of macrophage is involved in arsenicosis-induced hepatic fibrosis through the activation of hepatic stellate cells.
Xue J; Xiao T; Wei S; Sun J; Zou Z; Shi M; Sun Q; Dai X; Wu L; Li J; Xia H; Tang H; Zhang A; Liu Q
J Cell Physiol; 2021 Aug; 236(8):6025-6041. PubMed ID: 33481270
[TBL] [Abstract][Full Text] [Related]
4. Regulation of gasdermin D by miR-379-5p is involved in arsenite-induced activation of hepatic stellate cells and in fibrosis via secretion of IL-1β from human hepatic cells.
Li J; Xue J; Wang D; Dai X; Sun Q; Xiao T; Wu L; Xia H; Mostofa G; Chen X; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Metallomics; 2019 Feb; 11(2):483-495. PubMed ID: 30643918
[TBL] [Abstract][Full Text] [Related]
5. microRNA-21, via the HIF-1α/VEGF signaling pathway, is involved in arsenite-induced hepatic fibrosis through aberrant cross-talk of hepatocytes and hepatic stellate cells.
Sun J; Shi L; Xiao T; Xue J; Li J; Wang P; Wu L; Dai X; Ni X; Liu Q
Chemosphere; 2021 Mar; 266():129177. PubMed ID: 33310519
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.
Riaz F; Chen Q; Lu K; Osoro EK; Wu L; Feng L; Zhao R; Yang L; Zhou Y; He Y; Zhu L; Du X; Sadiq M; Yang X; Li D
J Cell Mol Med; 2021 Apr; 25(8):4073-4087. PubMed ID: 33689215
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-191 blocking the translocation of GLUT4 is involved in arsenite-induced hepatic insulin resistance through inhibiting the IRS1/AKT pathway.
Li W; Wu L; Sun Q; Yang Q; Xue J; Shi M; Tang H; Zhang J; Liu Q
Ecotoxicol Environ Saf; 2021 Jun; 215():112130. PubMed ID: 33743404
[TBL] [Abstract][Full Text] [Related]
8. The interaction of hsa_circ_0002594 and eIF4A3 promotes T-helper 2 cell differentiation by the regulation of PTEN.
Wang J; Cheng Y
Clin Exp Med; 2023 Jul; 23(3):887-895. PubMed ID: 35870031
[TBL] [Abstract][Full Text] [Related]
9. [Rat serum containing oxymatrine inhibits the proliferation of LX2 human hepatic stellate cells induced by sodium arsenite via blocking PI3K/AKT pathway].
Yang L; Zhang J; Han X; Li C; Liu R; Ma Z; Han B; Xie R; Yang Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jul; 38(7):598-604. PubMed ID: 35786453
[TBL] [Abstract][Full Text] [Related]
10. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
11. miR-21 in EVs from pulmonary epithelial cells promotes myofibroblast differentiation via glycolysis in arsenic-induced pulmonary fibrosis.
Wang P; Xiao T; Li J; Wang D; Sun J; Cheng C; Ma H; Xue J; Li Y; Zhang A; Liu Q
Environ Pollut; 2021 Oct; 286():117259. PubMed ID: 33965804
[TBL] [Abstract][Full Text] [Related]
12. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K/AKT signaling pathway.
Huang Y; Fan X; Tao R; Song Q; Wang L; Zhang H; Kong H; Huang J
J Cell Physiol; 2018 Oct; 233(10):6693-6704. PubMed ID: 29323718
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miRNA-451a Promotes the Differentiation of CD4+ T Cells towards Th2 Cells by Upregulating ETS1 in Childhood Asthma.
Wang T; Zhou Q; Shang Y
J Innate Immun; 2021; 13(1):38-48. PubMed ID: 33271553
[TBL] [Abstract][Full Text] [Related]
14. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
Fu J; Wu B; Zhong S; Deng W; Lin F
Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
[TBL] [Abstract][Full Text] [Related]
15. Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics.
Huang Y; Luo W; Chen S; Su H; Zhu W; Wei Y; Qiu Y; Long Y; Shi Y; Wei J
Phytomedicine; 2023 Dec; 121():155117. PubMed ID: 37820467
[TBL] [Abstract][Full Text] [Related]
16. LncRNA H19-mediated M2 polarization of macrophages promotes myofibroblast differentiation in pulmonary fibrosis induced by arsenic exposure.
Xiao T; Zou Z; Xue J; Syed BM; Sun J; Dai X; Shi M; Li J; Wei S; Tang H; Zhang A; Liu Q
Environ Pollut; 2021 Jan; 268(Pt A):115810. PubMed ID: 33162208
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-101 suppresses liver fibrosis by downregulating PI3K/Akt/mTOR signaling pathway.
Lei Y; Wang QL; Shen L; Tao YY; Liu CH
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):575-584. PubMed ID: 30857885
[TBL] [Abstract][Full Text] [Related]
18. [Effects of sodium arsenite exposure on activation and extracellular matrix secretion of human hepatic stellate cells].
Fan LL; Chen X; Zou ZL; Wang DP; Zhang AH
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Oct; 52(10):983-987. PubMed ID: 30392314
[No Abstract] [Full Text] [Related]
19. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
Xiao Y; Wang J; Chen Y; Zhou K; Wen J; Wang Y; Zhou Y; Pan W; Cai W
Cell Signal; 2014 May; 26(5):925-32. PubMed ID: 24412919
[TBL] [Abstract][Full Text] [Related]
20. Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
Okamura K; Sato M; Suzuki T; Nohara K
Toxicol Appl Pharmacol; 2022 Nov; 454():116231. PubMed ID: 36089002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
